Single-dose Proportionality Assessment

Single-Dose Proportionality Assessment is a pharmacokinetic evaluation method used to determine the extent to which the systemic exposure to a drug increases proportionally with escalating doses following a single administration, under controlled experimental conditions.

3

Publications

107

Citations

16

Authors

5

Institutions

Publications per year

2017–2026

0

Authors

16

  1. SD
    Steve D. Thomas

    Bristol-Myers Squibb (Switzerland), Switzerland

    1 publications · 30 citations

    1

    h-index

  2. WT
    William Tracewell

    Teva Pharmaceuticals (United States), United States

    1 publications · 30 citations

    1

    h-index

  3. CB
    Christopher Banfield

    Pfizer (United States), United States

    1 publications · 31 citations

    1

    h-index

  4. MR
    Michael R. Scheffler

    Bristol-Myers Squibb (Switzerland), Switzerland

    1 publications · 30 citations

    1

    h-index

  5. MP
    Michael P. Adams

    Endo Pharmaceuticals (United States), United States

    1 publications · 46 citations

    1

    h-index

1–5 of 16

Venues

  1. Drugs in R&D

    1 publications · 46 citations

    1

    h-index

  2. Clinical Pharmacokinetics

    1 publications · 31 citations

    1

    h-index

  3. The Journal of Clinical Pharmacology

    1 publications · 30 citations

    1

    h-index

1–3